Ligand id: 6881

Name: tocilizumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: tocilizumab

Compound class Antibody
Approved drug? Yes (FDA (2010), EMA (2009))
International Nonproprietary Names
INN number INN
8394 tocilizumab
Actemra® | R-1569 | RG-1569 | RHPM-1 | RoActemra®
Tocilizumab is an aniti-IL-6 receptor mAb, with immunosuppressive action [6] that is approved for chronic autoimmune indications.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Database Links
Specialist databases
IMGT/mAb-DB 96
Other databases
GtoPdb PubChem SID 178103463
Immunopaedia Search tocilizumab
PubChem SID 178103463
Search PubMed clinical trials tocilizumab
Search PubMed titles tocilizumab
Search PubMed titles/abstracts tocilizumab
Wikipedia Tocilizumab